简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-02-10 16:30 U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
2026-02-09 11:42 Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke
2026-02-06 14:34 Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
2026-02-05 18:25 Menicon’s Largest Malaysia Plant Begins Commercial Production
2026-02-05 18:14 Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
2026-02-05 13:37 China NMPA Approves Promega MSI Detection Kit as Companion Diagnostic for KEYTRUDA®
2026-02-03 13:44 Tastepoint by IFF Predicts Ten Flavor Trends for 2026
2026-02-03 10:50 Ensem Therapeutics Doses First Patient in China in ETX-636 Global Phase 1/2 Study
2026-02-02 17:03 Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
2026-02-02 14:15 Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
2026-01-30 14:18 Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity
2026-01-30 14:03 Organon Completes Divestiture of JADA® System to Laborie
2026-01-29 15:48 Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis
2026-01-29 15:37 Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
2026-01-29 14:43 Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
2026-01-29 14:25 Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty
2026-01-28 18:00 PQE Group Reports Solid Year-End Results, Strengthens Position through Innovation in Pharmaceuticals and Medical Devices
2026-01-27 10:16 Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
2026-01-27 10:09 Fortitude Biomedicines Launches With $13M in Financing to Advance Novel Antibody-based Therapies for Treatment of Autoimmune Diseases and Cancer
2026-01-23 16:44 Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis

Business Wire Weibo

Press Releases

Latest Releases